Cargando…

Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study

BACKGROUND: Neuromyelitis optica spectrum disease (NMOSD) is a severe autoimmune demyelinating disorder of the central nervous system that throughout epidemiological data, it has not been completely determined. The aim of this study was to assess characteristics of NMOSD patients in Isfahan as one o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ashtari, Fereshte, Safaei, Ali, Shaygannejad, Vahid, Najafi, Mohammad Amin, Vesal, Sahar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393101/
https://www.ncbi.nlm.nih.gov/pubmed/28465700
http://dx.doi.org/10.4103/1735-1995.202142
_version_ 1783229535929499648
author Ashtari, Fereshte
Safaei, Ali
Shaygannejad, Vahid
Najafi, Mohammad Amin
Vesal, Sahar
author_facet Ashtari, Fereshte
Safaei, Ali
Shaygannejad, Vahid
Najafi, Mohammad Amin
Vesal, Sahar
author_sort Ashtari, Fereshte
collection PubMed
description BACKGROUND: Neuromyelitis optica spectrum disease (NMOSD) is a severe autoimmune demyelinating disorder of the central nervous system that throughout epidemiological data, it has not been completely determined. The aim of this study was to assess characteristics of NMOSD patients in Isfahan as one of the most prevalent cities for multiple sclerosis in Iran. MATERIALS AND METHODS: Forty-five patients diagnosed as neuromyelitis optica (NMO) disease through 5 years enrolled in this study. Demographics and characteristics of disease such as Expanded Disability Status Scale (EDSS) score, disease duration, clinical symptoms, laboratory data, and magnetic resonance imaging findings (including T1, T2, and flair protocols) were recorded. NMO-immunoglobulin G serology assay was done in all of the patients by ELISA test. RESULTS: Female to male ratio was 5.4:1. The mean age of disease onset was 29.8 ± 11.2 years. NMO antibody was positive in 24.4% of patients. The presenting symptoms were optic neuritis (55.5%), transverse myelitis (40%), and brainstem symptoms (4.5%). The interval between the first and second attack was 19.28 ± 31.27 months (range: 1 month to 17 years). The mean EDSS score of the patients was 2.8 ± 2.25. Frequency of long-extending cervical plaque was higher among men than women (85.7% vs. 57.9%). CONCLUSION: Based on this study, the mean age of NMOSD onset among Isfahan population was considerably lower than other studies, and there was higher frequency of long-extending cervical lesion among male patients which needs more consideration in further studies.
format Online
Article
Text
id pubmed-5393101
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-53931012017-05-02 Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study Ashtari, Fereshte Safaei, Ali Shaygannejad, Vahid Najafi, Mohammad Amin Vesal, Sahar J Res Med Sci Short Communication BACKGROUND: Neuromyelitis optica spectrum disease (NMOSD) is a severe autoimmune demyelinating disorder of the central nervous system that throughout epidemiological data, it has not been completely determined. The aim of this study was to assess characteristics of NMOSD patients in Isfahan as one of the most prevalent cities for multiple sclerosis in Iran. MATERIALS AND METHODS: Forty-five patients diagnosed as neuromyelitis optica (NMO) disease through 5 years enrolled in this study. Demographics and characteristics of disease such as Expanded Disability Status Scale (EDSS) score, disease duration, clinical symptoms, laboratory data, and magnetic resonance imaging findings (including T1, T2, and flair protocols) were recorded. NMO-immunoglobulin G serology assay was done in all of the patients by ELISA test. RESULTS: Female to male ratio was 5.4:1. The mean age of disease onset was 29.8 ± 11.2 years. NMO antibody was positive in 24.4% of patients. The presenting symptoms were optic neuritis (55.5%), transverse myelitis (40%), and brainstem symptoms (4.5%). The interval between the first and second attack was 19.28 ± 31.27 months (range: 1 month to 17 years). The mean EDSS score of the patients was 2.8 ± 2.25. Frequency of long-extending cervical plaque was higher among men than women (85.7% vs. 57.9%). CONCLUSION: Based on this study, the mean age of NMOSD onset among Isfahan population was considerably lower than other studies, and there was higher frequency of long-extending cervical lesion among male patients which needs more consideration in further studies. Medknow Publications & Media Pvt Ltd 2017-03-15 /pmc/articles/PMC5393101/ /pubmed/28465700 http://dx.doi.org/10.4103/1735-1995.202142 Text en Copyright: © 2017 Journal of Research in Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Short Communication
Ashtari, Fereshte
Safaei, Ali
Shaygannejad, Vahid
Najafi, Mohammad Amin
Vesal, Sahar
Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
title Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
title_full Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
title_fullStr Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
title_full_unstemmed Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
title_short Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross-sectional study
title_sort neuromyelitis optica spectrum disease characteristics in isfahan, iran: a cross-sectional study
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5393101/
https://www.ncbi.nlm.nih.gov/pubmed/28465700
http://dx.doi.org/10.4103/1735-1995.202142
work_keys_str_mv AT ashtarifereshte neuromyelitisopticaspectrumdiseasecharacteristicsinisfahaniranacrosssectionalstudy
AT safaeiali neuromyelitisopticaspectrumdiseasecharacteristicsinisfahaniranacrosssectionalstudy
AT shaygannejadvahid neuromyelitisopticaspectrumdiseasecharacteristicsinisfahaniranacrosssectionalstudy
AT najafimohammadamin neuromyelitisopticaspectrumdiseasecharacteristicsinisfahaniranacrosssectionalstudy
AT vesalsahar neuromyelitisopticaspectrumdiseasecharacteristicsinisfahaniranacrosssectionalstudy